What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review.

C. Brereton (Southampton, United Kingdom), K. Pontoppidan (Southampton, United Kingdom), T. Wallis (Southampton, United Kingdom), L. Richeldi (Rome, Italy), M. Jones (Southampton, United Kingdom), S. Fletcher (Southampton, United Kingdom)

Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Session: Treatment and prognosis of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1348
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Brereton (Southampton, United Kingdom), K. Pontoppidan (Southampton, United Kingdom), T. Wallis (Southampton, United Kingdom), L. Richeldi (Rome, Italy), M. Jones (Southampton, United Kingdom), S. Fletcher (Southampton, United Kingdom). What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review.. 1348

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors influencing Idiopathic Pulmonary Fibrosis (IPF) anti-fibrotic decisions in a single UK centre; patient and physician perspectives
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018

Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres
Source: International Congress 2016 – IPF treatment II
Year: 2016



Inappropriate prescriptions following initial COPD diagnosis
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Audit of quality of reviews of COPD patients in a UK primary care practice
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013


Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009


Do we treat different COPD patients depending on the guideline we use?
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014

Family physicians step therapy up in symptomatic COPD patients differently than respiratory specialists
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD management
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Year: 2014


What are common COPD symptoms in a real-life setting? The German DACCORD registry
Source: International Congress 2014 – COPD markers
Year: 2014

A retrospective audit of chronic obstructive pulmonary disease (COPD) admissions to a university teaching hospital after publication of the British Thoracic Society (BTS) guidelines
Source: Eur Respir J 2001; 18: Suppl. 33, 26s
Year: 2001

LATE-BREAKING ABSTRACT: Knowledge, attitudes and practice of medical doctors in diagnosis and management of COPD patients in Vietnam
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014


Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Drug treatment in a German real-life COPD cohort (DACCORD)
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


International guidelines for the chronic obstructive pulmonary disease (COPD) and the real therapeutic management of patients in Greece from pulmonologists and general practitioners (GPs)
Source: Eur Respir J 2002; 20: Suppl. 38, 398s
Year: 2002

Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Eur Respir Rev 2009; 18: 272-290
Year: 2009



Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Guideline 2009
Year: 2009

Emergency department (ED) attendance with asthma: An unmet need for specialist review
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016